Skip to content

Differentiated Thyroid Carcinoma

Differentiated thyroid carcinoma is a form of thyroid cancer that includes papillary and follicular tumours, which are often curable, along with less common poorly differentiated and undifferentiated types.

Nexavar

Sorafenib

200mg

Sorafenib tablets for liver and kidney cancer. It blocks the growth of new blood vessels that tumours need to grow.

From$5.24/ tabletView

Key points

  • Papillary and follicular tumours are the well-differentiated forms of this carcinoma and tend to respond to treatment.
  • Sorafenib is the ingredient in the medicine listed for this condition and belongs to a class of targeted therapies.

Common questions about Differentiated Thyroid Carcinoma

What is differentiated thyroid carcinoma?

Differentiated thyroid carcinoma covers papillary and follicular tumours of the thyroid, which are often curable, along with less common poorly differentiated and undifferentiated types.

Which medicine is listed for differentiated thyroid carcinoma?

The listed product is Nexavar, a 200mg tablet containing sorafenib, marketed by Bayer and used in the treatment of this carcinoma.

Further reading